Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design ...
Nanoscope Therapeutics has reported data from a mid-stage clinical trial that suggests its optogenetic therapy based on light-sensitive molecules is an effective treatment for incurable eye ...
Retinitis Pigmentosa (RP), a genetic disorder, causes the progressive breakdown of rod cells, while cataracts (clouding of the eye’s lens), glaucoma (damage of the optic nerve), diabetic ...
Retinitis Pigmentosa (RP), a genetic disorder, causes the progressive breakdown of rod cells, while cataracts (clouding of the eye’s lens), glaucoma (damage of the optic nerve), diabetic ...